Comparing losartan with enalapril in congestive heart failure

Research output: Contribution to journalArticle

Abstract

We compared the effects of losartan and enalapril on exercise oxygen uptake, diffusing capacity of lung for carbon monoxide, and evaluated the consequences of cyclo-oxygenase and prostaglandin inhibition in 16 patients with congestive heart failure and 8 controls. In patients, but not in controls, losartan and enalapril similarly improved exercise tolerance and oxygen uptake. This effect was inhibited, however, by cyclooxygenase blockade with aspirin while patients were taking enalapril and not losartan. Our findings suggest that because losartan's effect is dissociated from prostaglandin activation, it may be an advancement for the treatment of patients with congestive heart failure and coronary artery disease in whom aspirin is indicated.

Original languageEnglish
Pages (from-to)26-30
Number of pages5
JournalCardiology Review
Volume15
Issue number10
Publication statusPublished - 1998

Fingerprint

Enalapril
Losartan
Heart Failure
Prostaglandin-Endoperoxide Synthases
Aspirin
Oxygen
Lung Volume Measurements
Exercise Tolerance
Carbon Monoxide
Prostaglandins
Coronary Artery Disease
Exercise
Therapeutics

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Comparing losartan with enalapril in congestive heart failure. / Guazzi, M.; Agostoni, P.

In: Cardiology Review, Vol. 15, No. 10, 1998, p. 26-30.

Research output: Contribution to journalArticle

@article{5b7102a26cee46b7a214225c66bb8f5d,
title = "Comparing losartan with enalapril in congestive heart failure",
abstract = "We compared the effects of losartan and enalapril on exercise oxygen uptake, diffusing capacity of lung for carbon monoxide, and evaluated the consequences of cyclo-oxygenase and prostaglandin inhibition in 16 patients with congestive heart failure and 8 controls. In patients, but not in controls, losartan and enalapril similarly improved exercise tolerance and oxygen uptake. This effect was inhibited, however, by cyclooxygenase blockade with aspirin while patients were taking enalapril and not losartan. Our findings suggest that because losartan's effect is dissociated from prostaglandin activation, it may be an advancement for the treatment of patients with congestive heart failure and coronary artery disease in whom aspirin is indicated.",
author = "M. Guazzi and P. Agostoni",
year = "1998",
language = "English",
volume = "15",
pages = "26--30",
journal = "Cardiology Board Review",
issn = "1092-6607",
publisher = "Ascend Media",
number = "10",

}

TY - JOUR

T1 - Comparing losartan with enalapril in congestive heart failure

AU - Guazzi, M.

AU - Agostoni, P.

PY - 1998

Y1 - 1998

N2 - We compared the effects of losartan and enalapril on exercise oxygen uptake, diffusing capacity of lung for carbon monoxide, and evaluated the consequences of cyclo-oxygenase and prostaglandin inhibition in 16 patients with congestive heart failure and 8 controls. In patients, but not in controls, losartan and enalapril similarly improved exercise tolerance and oxygen uptake. This effect was inhibited, however, by cyclooxygenase blockade with aspirin while patients were taking enalapril and not losartan. Our findings suggest that because losartan's effect is dissociated from prostaglandin activation, it may be an advancement for the treatment of patients with congestive heart failure and coronary artery disease in whom aspirin is indicated.

AB - We compared the effects of losartan and enalapril on exercise oxygen uptake, diffusing capacity of lung for carbon monoxide, and evaluated the consequences of cyclo-oxygenase and prostaglandin inhibition in 16 patients with congestive heart failure and 8 controls. In patients, but not in controls, losartan and enalapril similarly improved exercise tolerance and oxygen uptake. This effect was inhibited, however, by cyclooxygenase blockade with aspirin while patients were taking enalapril and not losartan. Our findings suggest that because losartan's effect is dissociated from prostaglandin activation, it may be an advancement for the treatment of patients with congestive heart failure and coronary artery disease in whom aspirin is indicated.

UR - http://www.scopus.com/inward/record.url?scp=0031774244&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031774244&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0031774244

VL - 15

SP - 26

EP - 30

JO - Cardiology Board Review

JF - Cardiology Board Review

SN - 1092-6607

IS - 10

ER -